*By Carlo Versano*
A new start-up wants to help patients and caregivers with the age-old problem of managing medications for chronic or serious illnesses.
Hero sprang from the mind of Kal Vepuri, whose aptly-named Brainchild Holdings led a $12 million investment round for the company, which produces an eponymous counter-top device that can store and dispense pills in pre-selected dosages at certain times.
Vepuri told Cheddar he came up with the idea after he became a caregiver for his ill mother.
"She took almost a dozen medications at one point," he said, and the task of organizing, remembering, and dispensing them, as well as dealing with multiple prescribing physicians and changing dosages became an overwhelming task.
So Vepuri took his experience as an entrepreneur and tech consultant to build Hero, which resembles a kitchen appliance married to an Apple device.
The problems surrounding medication management are what he called a "phantom issue" ー no one wants to talk about it, but a stunning number of people have to deal with it ー 70 million Americans have multiple chronic diseases, Vepuri said, and that number will unfortunately only go up as Baby Boomers age, and more millennials are tasked with taking care of their older parents (one-fourth of caregivers are already millennials).
"It's not really great dinner table conversation," he said, "But when you're one-on-one with somebody, and they bring up a problem that they've faced themselves and has been so personal to them and their family, they tend to understand it immediately."
The Hero device can't tell if a user has actually taken his or her pills, but it can remind that person (or a family member or caregiver) through an app notification.
Vepuri said he plans to use the new funding to educate consumers and develop partnerships and online direct-to-caregiver systems so that Hero can be a closed-loop solution for caregivers and patients alike.
For full interview [click here](https://cheddar.com/videos/healthcare-start-up-hero-launches-with-12-million-seed-funding).
Sinead O’Sullivan breaks down Taylor Swift’s genius marketing for The Life of a Showgirl, which just set the record for most albums sold in a single week.
Markets are emerging from a turbulent Q3. Horizon’s Mike Dickson shares insights on interest rates, small caps, and where investors should look in Q4 and beyond
Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
Former Cisco Systems CEO John Chambers learned all about technology’s volatile highs and lows as a veteran of the internet’s early boom days during the late 1990s and the ensuing meltdown that followed the mania. And now he is seeing potential signs of the cycle repeating with another transformative technology in artificial intelligence. Chambers is trying take some of the lessons he learned while riding a wave that turned Cisco into the world's most valuable company in 2000 before a crash hammered its stock price and apply them as an investor in AI startups. He recently discussed AI's promise and perils during an interview with The Associated Press.
Grove Collaborative’s CEO shares how the company is reinventing everyday goods with sustainability at the core and working toward a plastic-free future.
Atlanta Mayor Andre Dickens shares plans for affordable housing, community-led growth, and why private and public grocery stores could be key to food equity.
Tesla reported a surprise increase in sales in the third quarter as the electric car maker likely benefited from a rush by consumers to take advantage of a $7,500 credit before it expired on Sept. 30. The company reported Thursday that sales in the three months through September rose 7% compared to the same period a year ago. The gain follows two quarters of steep declines as people turned off by CEO Elon Musk’s foray into right-wing politics avoided buying his company’s cars and even protested at some dealerships. Sales rose to 497,099 vehicles, compared with 462,890 in the same period last year.
